安必平收盘上涨3.82%，滚动市盈率1238.65倍，总市值27.71亿元

Company Overview - Anbiping's closing price on July 11 was 29.62 yuan, up 3.82%, with a rolling PE ratio of 1238.65, marking a new low in 22 days, and a total market capitalization of 2.771 billion yuan [1] - The company operates in the medical device industry, focusing on tumor screening and diagnostic reagents, automation equipment, and auxiliary diagnostic AI software [1] Financial Performance - For Q1 2025, Anbiping reported revenue of 72.5435 million yuan, a year-on-year decrease of 28.51%, and a net loss of approximately 11.0645 million yuan, a year-on-year decline of 238.49%, with a gross profit margin of 61.97% [1] Industry Comparison - The average PE ratio for the medical device industry is 52.06, with a median of 37.22, placing Anbiping at the 122nd position in the industry ranking [1] - Other companies in the industry have significantly lower PE ratios, with the highest being 18.97 for Sanxin Medical [2]